D.A. Davidson & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.96M Buy
18,575
+2,824
+18% +$765K 0.03% 399
2025
Q4
$3.95M Buy
15,751
+1,290
+9% +$343K 0.02% 446
2025
Q3
$4.15M Buy
14,461
+1,103
+8% +$296K 0.03% 423
2025
Q2
$3.51M Buy
13,358
+1,507
+13% +$367K 0.02% 426
2025
Q1
$2.76M Buy
11,851
+204
+2% +$49.5K 0.02% 478
2024
Q4
$2.67M Buy
11,647
+1,422
+14% +$326K 0.02% 477
2024
Q3
$2.29M Sell
10,225
-1,233
-11% -$271K 0.02% 514
2024
Q2
$2.33M Sell
11,458
-1,709
-13% -$348K 0.02% 497
2024
Q1
$2.88M Buy
13,167
+4,772
+57% +$1.05M 0.03% 432
2023
Q4
$1.91M Sell
8,395
-764
-8% -$160K 0.02% 519
2023
Q3
$1.84M Sell
9,159
-1,359
-13% -$287K 0.02% 498
2023
Q2
$2.18M Buy
10,518
+563
+6% +$109K 0.02% 464
2023
Q1
$1.94M Sell
9,955
-88
-0.9% -$18.1K 0.02% 473
2022
Q4
$2.03M Buy
10,043
+192
+2% +$37.5K 0.02% 438
2022
Q3
$1.75M Sell
9,851
-51
-0.5% -$10.4K 0.02% 439
2022
Q2
$1.99M Sell
9,902
-110
-1% -$23.4K 0.03% 421
2022
Q1
$2.27M Buy
10,012
+118
+1% +$27.8K 0.02% 429
2021
Q4
$2.67M Sell
9,894
-61
-0.6% -$15.1K 0.03% 396
2021
Q3
$2.41M Sell
9,955
-19
-0.2% -$4.79K 0.03% 395
2021
Q2
$2.36M Sell
9,974
-62
-0.6% -$14.1K 0.03% 402
2021
Q1
$2.2M Buy
10,036
+2,237
+29% +$449K 0.03% 386
2020
Q4
$1.35M Buy
7,799
+58
+0.7% +$10K 0.02% 434
2020
Q3
$1.25M Sell
7,741
-142
-2% -$22.5K 0.02% 400
2020
Q2
$1.13M Sell
7,883
-1,821
-19% -$252K 0.02% 422
2020
Q1
$1.09M Buy
9,704
+397
+4% +$57.2K 0.02% 426
2019
Q4
$1.35M Sell
9,307
-2,818
-23% -$407K 0.02% 435
2019
Q3
$1.75M Buy
12,125
+179
+1% +$26.1K 0.03% 374
2019
Q2
$1.77M Buy
11,946
+1,666
+16% +$232K 0.03% 358
2019
Q1
$1.35M Sell
10,280
-755
-7% -$93K 0.02% 445
2018
Q4
$1.2M Buy
11,035
+295
+3% +$39.5K 0.02% 441
2018
Q3
$1.6M Buy
10,740
+545
+5% +$82.9K 0.03% 403
2018
Q2
$1.57M Buy
10,195
+1,489
+17% +$225K 0.03% 391
2018
Q1
$1.21M Hold
8,706
0.03% 436
2017
Q4
$1.19M Sell
8,706
-547
-6% -$72.3K 0.03% 426
2017
Q3
$1.2M Buy
9,253
+888
+11% +$118K 0.02% 448
2017
Q2
$1.11M Buy
8,365
+7,569
+951% +$927K 0.03% 432
2017
Q1
$98K Sell
796
-36,407
-98% -$4.31M ﹤0.01% 1256
2016
Q4
$4.1M Buy
37,203
+724
+2% +$80.4K 0.09% 210
2016
Q3
$4.31M Buy
36,479
+361
+1% +$42.5K 0.11% 192
2016
Q2
$4.04M Sell
36,118
-506
-1% -$54.5K 0.12% 173
2016
Q1
$3.68M Buy
36,624
+839
+2% +$80.4K 0.11% 179
2015
Q4
$3.8M Sell
35,785
-969
-3% -$100K 0.12% 166
2015
Q3
$3.42M Buy
36,754
+4,470
+14% +$462K 0.12% 175
2015
Q2
$3.36M Sell
32,284
-1,393
-4% -$145K 0.11% 183
2015
Q1
$3.65M Sell
33,677
-592
-2% -$60.9K 0.12% 180
2014
Q4
$3.17M Sell
34,269
-1,267
-4% -$112K 0.1% 204
2014
Q3
$3.1M Buy
35,536
+1,452
+4% +$131K 0.11% 195
2014
Q2
$3M Sell
34,084
-1,079
-3% -$93.5K 0.1% 204
2014
Q1
$2.97M Sell
35,163
-815
-2% -$65K 0.11% 192
2013
Q4
$2.82M Sell
35,978
-404
-1% -$34.5K 0.11% 197
2013
Q3
$3.1M Buy
36,382
+1,805
+5% +$152K 0.14% 152
2013
Q2
$2.97M Buy
+34,577
New +$2.87M 0.14% 145

Other funds holding LH

D.A. Davidson & Co's LH Position: Q1 2026 in Review

D.A. Davidson & Co increased its Labcorp (LH) stake by 18% in Q1 2026, buying an estimated $765K and bringing the position to 18,575 shares worth $4.96M. The position accounts for 0.03% of the portfolio, ranked #399.

D.A. Davidson & Co first reported a position in LH in Q2 2013 and has held it in 52 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • D.A. Davidson & Co held 18,575 shares of Labcorp worth $4.96M as of Q1 2026.
  • D.A. Davidson & Co bought 2,824 Labcorp shares in Q1 2026, an estimated $765K.
  • Labcorp made up 0.03% of D.A. Davidson & Co's portfolio in Q1 2026, its #399 holding.
  • D.A. Davidson & Co first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.